483
ABO Plasma Glassboro LLCABO Plasma Glassboro LLC – FDA 483, Mar 14, 2023
Record Details
An FDA inspection of ABO Plasma Glassboro LLC, a plasmapheresis center, revealed a significant failure in donor notification procedures. The firm did not make reasonable attempts to notify deferred donors within the required 8-week period, specifically for HCV reactive donors. This indicates a serious lapse in donor safety and regulatory compliance.
View Company Profile
ID · 950fad97-070d-4c31-9755-5adfb68ef661
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.